Breast cancer is the most common malignancy and the second most common cause of cancer
deaths in American women. The American Cancer Society estimates that 207,090 new cases
of invasive breast cancer and 40,230 breast cancer deaths are expected in 2010 [
[1]
]. In patients with primary breast cancer, axillary lymph node status remains one of
the most important prognostic indicators.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer facts and figures 2010.American Cancer Society, Atlanta (GA)2010 (p. 8–9)
- Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg. 1992; 127: 392-399
- Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg. 1994; 220: 391-401
- American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.J Clin Oncol. 2005; 23: 7703-7720
- Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute Conference.J Clin Oncol. 2008; 28: 791-797
- Surgical resection and radiolocalization of the sentinel lymph node breast cancer using a gamma probe.Surg Oncol. 1993; 2: 335-339
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet. 1997; 349: 1864-1867
- Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.J Am Coll Surg. 1998; 186: 275-283
- Lessons learned from 500 cases of lymphatic mapping for breast cancer.Ann Surg. 1999; 229: 528-535
- Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10mCi radiocolloid in combination with a blue dye tracer.Eur J Surg Oncol. 1999; 25: 24-29
- Sentinel lymph node dissection.in: Harris J.R. Lippman M.E. Morrow M. Disease of the breast. 4th edition. Lippincott Williams & Wilkins, Philadelphia2010: 547
- Lymphoscintigraphy and radio-guided biopsy of the sentinel axillary node in breast cancer.J Nucl Med. 1998; 39: 2080-2084
- Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy.J Nucl Med. 2000; 41: 1682-1688
- Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes.Ann Surg. 2000; 231: 724-731
- Staging of breast cancer, a new rationale for internal mammary node biopsy.Arch Surg. 1981; 116: 748-751
- The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study.Ann Surg Oncol. 2008; 15: 863-871
- Alternative sites of injection for sentinel lymph node biopsy in breast cancer.ANZ J Surg. 2003; 73: 600-604
- Current controversies in sentinel lymph node biopsy for breast cancer.Breast. 2003; 12: 163-171
- Current controversies concerning sentinel lymph node biopsy for breast cancer.Breast Cancer Res Treat. 2004; 84: 261-271
- Intradermal blue dye to identify sentinel lymph nodes in breast cancer.Lancet. 1997; 349: 1668-1669
- Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.Ann Surg Oncol. 1999; 6: 450-454
- Subareolar versus peritumoral injection for location of the sentinel node.Am Surg. 1999; 6: 860-865
- Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.J Am Coll Surg. 1999; 189: 539-545
- Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.Ann Surg Oncol. 2006; 13: 1412-1421
- Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRASENODE trial.J Clin Oncol. 2007; 24: 3664-3669
- Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of the multi-institutional study.Ann Surg. 2001; 233: 767-787
- Intradermal isotope injection is superior to intramammary in sentinel sentinel node biopsy for breast cancer.Surgery. 2001; 130: 432-438
- Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer.Lancet. 2001; 357: 122
- Sentinel node skills verification and surgeon performance data from a multicenter clinical trial for early-stage breast cancer.Ann Surg. 2005; 242: 593-602
- Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.Surgery. 1999; 126: 714-720
- Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alone with triple modality localization.ANZ J Surg. 2003; 73: 815-818
- Review of sentinel lymph node credentialing: how many cases are enough?.J Am Coll Surg. 2001; 193: 206-209
The American Society of Breast Surgeons. Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer. 2000. Available at: http://www.breastsurgeons.org/statements/PDF_Statements/SLN_Dissection.pdf.
The American Society of Breast Surgeons. Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer. 2005. Available at: http://www.breastsurgeons.org/statements/PDF_Statements/SLN_Dissection.pdf.
- Technical outcomes of sentinel-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomized phase III trial.Lancet Oncol. 2007; 8: 881-888
- Sentinel lymph node biopsy for breast: how many nodes are enough?.J Surg Oncol. 2007; 96: 554-559
- Are 3 sentinel nodes sufficient?.Arch Surg. 2007; 142: 456-460
- Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer – results of the ALMANAC validation phase.Breast Cancer Res Treat. 2006; 99: 203-208
- Sentinel-lymph-node resection compared with axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.Lancet Oncol. 2010; 11: 927-933
- Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.J Surg Oncol. 2010; 102: 111-118
- Sentinel lymph node biopsy versus axillary clearance in operable breast cancer. The RACS SNAC trial. A multicenter randomized trial of the Royal Australian College of Surgeons (RACS) section of breast surgery in collaboration with the National Health and Medical Research Council Clinical Trials Center.Ann Surg Oncol. 2004; 11: 216S-221S
- SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.Ann Surg Oncol. 2009; 16: 266-275
- A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer. Results of the Sentinella/GIVOM trial.Ann Surg. 2008; 247: 207-213
- Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale.Mod Pathol. 2010; 23: S26-S32
- Edge S.B. Byrd D.R. Compton C.C. AJCC cancer staging manual. 7th edition. Springer, New York2010: 347-376
- Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.J Clin Oncol. 2000; 18: 2553-2559
- Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study of 479 breast cancer patients.Eur J Surg Oncol. 2005; 31: 715-720
- Axillary recurrence rate after negative sentinel node biopsy in breast cancer. Three-year follow-up of the Swedish multicenter cohort study.Ann Surg. 2008; 247: 150-156
- The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up of 4,008 procedures.Ann Surg. 2004; 240: 462-471
- Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.Ann Surg. 2010; 251: 595-600
- Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature.Eur J Surg Oncol. 2008; 34: 1277-1284
- Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.N Engl J Med. 2002; 347: 567-575
- The time has come to change the algorithm for the surgical management of early breast cancer.Arch Surg. 2002; 137: 1131-1135
- A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram.Ann Surg. 2007; 245: 462-468
- Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection.Ann Surg Oncol. 2003; 10: 126-130
- Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes.Arch Surg. 2003; 138: 52-56
- Axillary recurrence following sentinel node biopsy.Ann Surg Oncol. 2005; 11: S58
- Comparison of radical mastectomy with alternative treatments for primary nreast cancer. A first report of results from a prospective randomized clinical trial.Cancer. 1977; 39: 2827-2839
- A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.Ann Surg. 2005; 242 ([discussion: 7–9]): 1-6
- Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study group trial 10–93.J Clin Oncol. 2006; 24: 337-344
- Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run.Radiother Oncol. 2003; 68: 233-240
- Locoregional recurrence after sentinel lymph node dissection with and without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 Randomized Trial.Ann Surg. 2010; 252: 426-432
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials.Lancet. 2005; 366: 2087-2106
Article info
Identification
Copyright
© 2011 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
